New Vaccine Bring Hope For Those Who Are Fighting Prostate Cancer
Researchers say the compound, called APC8015 (Provenge), primes patients’ immune systems to recognize and kill prostate cancer cells that have spread throughout the body.In a trial of 127 men with advanced disease, patients given the vaccine, called Provenge, experienced an average 18 percent increase in survival, compared to those on a placebo, the scientists report.”For … Read more